Andera Partners | WebDisclosure

PRESS RELEASE

published on 10/22/2025 at 09:00, 9 months 28 days ago

Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology by acquiring all shares of ImCheck. Anticipated acquisition focuses on ICT01 program for acute myeloid leukemia. Transaction details and advisors highlighted

Acquisition Oncology Ipsen ImCheck Therapeutics ICT01
BRIEF

published on 10/16/2025 at 11:10, 10 months 3 days ago

Andera Partners co-dirige une levée de fonds de série A de 105 millions d'euros pour Adcytherix

Investissement Andera Partners Traitements Contre Le Cancer Adcytherix BioDiscovery 7
BRIEF

published on 10/16/2025 at 11:10, 10 months 3 days ago

Andera Partners Co-Leads €105 Million Series A for Adcytherix

Investment Andera Partners Cancer Treatments Adcytherix BioDiscovery 7
PRESS RELEASE

published on 10/16/2025 at 11:05, 10 months 3 days ago

Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund
Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment

Andera Partners ADC Series A Adcytherix BioDiscovery 7
BRIEF

published on 10/15/2025 at 11:15, 10 months 4 days ago

Andera Partners Commits to Tubulis' €308 Million Series C for ADC Development

Series C Financing Andera Partners Tubulis ADC Development Clinical Expansion
BRIEF

published on 10/15/2025 at 11:15, 10 months 4 days ago

Andera Partners s'engage dans la série C de Tubulis, d'un montant de 308 millions d'euros, pour le développement d'ADC

Andera Partners Tubulis Développement ADC Financement De Série C Expansion Clinique
PRESS RELEASE

published on 10/15/2025 at 11:10, 10 months 4 days ago

Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors

Series C Financing Clinical Development Andera Partners Tubulis ADC Candidate
BRIEF

published on 06/12/2025 at 10:05, 1 year 2 months ago

Andera Partners Expands Mezzanine Sponsorless Strategy with Key Appointments

Andera Partners Strategic Appointments European Markets International Development Mezzanine Sponsorless
BRIEF

published on 06/12/2025 at 10:05, 1 year 2 months ago

Andera Partners élargit sa stratégie de financement mezzanine sans sponsor avec des nominations clés

Développement International Andera Partners Marchés Européens Nominations Stratégiques Mezzanine Sans Sponsor
PRESS RELEASE

published on 06/12/2025 at 10:00, 1 year 2 months ago

Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments
Andera Partners expands Mezzanine Sponsorless business internationally with two strategic appointments, reinforcing European private financing strategy

Andera Partners Strategic Appointments International Development Mezzanine Sponsorless Private Financing

Published on 08/19/2026 at 16:00, 2 hours 6 minutes ago

Telefónica Chile and Amdocs Establish Strategic Multi-Year Agreement to Accelerate Modernization and Business Agility in Chile
Published on 08/19/2026 at 15:55, 2 hours 11 minutes ago

Drill Permit Received for Storm Exploration's Gold Standard Project
Published on 08/19/2026 at 14:40, 3 hours 26 minutes ago

Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Published on 08/19/2026 at 13:00, 5 hours 6 minutes ago

UraniumX Discovery Corp. Provides Update On Transaction With Pond Technologies Holdings INC.
Published on 08/19/2026 at 13:00, 5 hours 6 minutes ago

Abasca Announces Positive Preliminary Economic Assessment for the Loki Flake Graphite Deposit: After-Tax NPV of US$130 Million and 16.7% IRR

View all ACCESSWIRE

Published on 08/19/2026 at 17:37, 28 minutes ago

Monthly Performance Factsheet
Published on 08/19/2026 at 16:51, 1 hour 14 minutes ago

AUTODOC and Apollo Funds successfully conclude transformative partnership
Published on 08/19/2026 at 16:15, 1 hour 50 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/19/2026 at 16:14, 1 hour 51 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/19/2026 at 16:14, 1 hour 52 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc

View all EQS

Published on 08/18/2026 at 18:00, 1 day ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 6 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 6 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 22 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE

News